Literature DB >> 33826992

Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial.

Kelsey T Laird1, Annette L Stanton2.   

Abstract

BACKGROUND: The benefits of written expressive disclosure (WED) to health are documented in a variety of healthy and clinical populations. This study investigates the effect of WED on health-related outcomes in irritable bowel syndrome (IBS).
METHODS: Adults (N = 189) meeting Rome III criteria for IBS were randomly assigned to write about their: (1) deepest thoughts and feelings about the most stressful life event of the past five years (n = 67), (2) deepest thoughts and feelings about their IBS (n = 61) or (3) daily activities in an objective manner (control condition; n = 61). Participants completed four 20-min writing sessions over 2-6 weeks. Gastrointestinal (GI) symptoms, healthcare utilization, health-related quality of life (HR-QOL), pain catastrophizing, and pain self-efficacy were assessed at baseline, one month post-writing completion, and three months post-writing completion.
RESULTS: A significant group (combined WED vs. control) X time interaction was detected for healthcare utilization, F(1,147) = 6.16, p = 0.014, η2 = 0.04. Specifically, number of GI-related medical appointments significantly increased from baseline to 3-month follow-up in the control group, while no significant change was observed in the combined WED group. Among the WED group, individuals assigned to write about their IBS experienced greater improvements in pain self-efficacy than those assigned to write about a life stressor, F(1,92) = 3.89, p = 0.024, η2 = 0.08. GI symptom severity, HR-QOL, and pain catastrophizing improved significantly across groups over time, with no significant between-group differences.
CONCLUSION: Writing about one's deepest thoughts and feelings about IBS may increase pain self-efficacy and reduce healthcare utilization compared to control writing in adults with IBS.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic pain; Disorders of gut-brain interaction; Expressive writing; Irritable bowel syndrome; Journaling; Minimal-contact

Mesh:

Year:  2021        PMID: 33826992      PMCID: PMC8172117          DOI: 10.1016/j.ctcp.2021.101374

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  46 in total

1.  Randomized Controlled Trial of Online Expressive Writing to Address Readjustment Difficulties Among U.S. Afghanistan and Iraq War Veterans.

Authors:  Nina A Sayer; Siamak Noorbaloochi; Patricia A Frazier; James W Pennebaker; Robert J Orazem; Paula P Schnurr; Maureen Murdoch; Kathleen F Carlson; Amy Gravely; Brett T Litz
Journal:  J Trauma Stress       Date:  2015-10

2.  Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects.

Authors:  Carissa A Low; Annette L Stanton; Sharon Danoff-Burg
Journal:  Health Psychol       Date:  2006-03       Impact factor: 4.267

3.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

Authors:  Rebecca M Lovell; Alexander C Ford
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-15       Impact factor: 11.382

4.  Costs of care for irritable bowel syndrome patients in a health maintenance organization.

Authors:  R L Levy; M Von Korff; W E Whitehead; P Stang; K Saunders; P Jhingran; V Barghout; A D Feld
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  A test of written emotional disclosure as an intervention for posttraumatic stress disorder.

Authors:  Denise M Sloan; Brian P Marx; Eva M Greenberg
Journal:  Behav Res Ther       Date:  2011-03-01

6.  Expressive writing is a promising therapeutic modality for the management of IBS: a pilot study.

Authors:  Albena Halpert; Denis Rybin; Gheorghe Doros
Journal:  Am J Gastroenterol       Date:  2010-06-15       Impact factor: 10.864

7.  Further examination of the exposure model underlying the efficacy of written emotional disclosure.

Authors:  Denise M Sloan; Brian P Marx; Eva M Epstein
Journal:  J Consult Clin Psychol       Date:  2005-06

8.  Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome.

Authors:  Brjánn Ljótsson; Hugo Hesser; Erik Andersson; Jeffrey M Lackner; Samir El Alaoui; Lisa Falk; Kristina Aspvall; Josefin Fransson; Klara Hammarlund; Anna Löfström; Sanna Nowinski; Perjohan Lindfors; Erik Hedman
Journal:  Behav Res Ther       Date:  2014-02-10

Review 9.  Are self-administered or minimal therapist contact psychotherapies an effective treatment for irritable bowel syndrome (IBS): a systematic review.

Authors:  Alyce Ahl; Antonina Mikocka-Walus; Andrea Gordon; Jane M Andrews
Journal:  J Psychosom Res       Date:  2013-05-30       Impact factor: 3.006

Review 10.  The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases.

Authors:  Aristofanis Gikas; John K Triantafillidis
Journal:  Int J Gen Med       Date:  2014-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.